WVXU: How far would you go to extend the life of a beloved pet?
The University of Cincinnati Blue Ash College's Jennifer Wells, DVM, was a recent panelist on WVXU's Cincinnati Edition discussing a new drug being developed designed to extend the lives of dogs.
Wells said while the exact way the drug works has not been disclosed, it is believed to focus on a hormone called IGF-1 that is thought to be elevated in larger-breed dogs and may contribute to dogs both growing bigger and declining faster.
"From what they’re saying, it looks to target that and kind of slow that mechanism down to a more reasonable pace that we might see in a medium-sized dog or even a smaller dog," said Wells, professor and chair of UC Blue Ash College's Veterinary Technology Department.
According to Wells, it appears the science is reasonable and could potentially be applied to species beyond dogs, including humans. But, she said, the drug raises additional moral and ethical questions.
"There’s a big dimension that we walk into when we have an elderly pet with the owner and talking about quality of life versus quantity," she said.
Listen to the Cincinnati Edition segment.
Featured photo at top of a dog. Photo/Unsplash/Vlad Rudkov.
About UC Blue Ash College
UC Blue Ash College is a regional college within the University of Cincinnati. It offers one of the best values in higher education with access to a nationally recognized UC education in more than 50 degree and certificate programs, as well as tuition that is about half of most colleges and universities. The college is located on a scenic 135-acre wooded campus in the heart of Blue Ash, Ohio. To learn more, call 513-558-9495, visit us online, like us on Facebook or follow us on Twitter and Instagram.
Related Stories
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.
Dual-arm robot stabilizes satellite for repairs in space
March 13, 2026
Interesting Engineering highlights an aerospace engineering research project examining novel ways to keep repair robots oriented in space.